Welcome to our dedicated page for ETRACS Whitney US Critical Technologies ETN SEC filings (Ticker: WUCT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
UBS AG filings for WUCT document foreign private issuer reporting and securities-offering disclosures for the ETRACS Whitney US Critical Technologies ETN. The record includes Form 6-K reports, Form 20-F references, IFRS consolidated financial information, capitalization disclosures, and debt and equity presentation for UBS AG and its subsidiaries.
Registration-related filings also incorporate Form F-3 materials and legal opinion exhibits for UBS AG securities offerings. These disclosures address the issuer's reporting framework, capital structure, funding from UBS Group AG, and the formal documentation supporting registered securities.
Pricing supplement overview: UBS AG London Branch will issue $12 million of Buffered Contingent Income Auto-Callable Securities with Memory Coupon and Downside Leverage, maturing 30 June 2026 and linked to the common stock of Merck & Co., Inc. (MRK).
Key structural terms:
- Stated principal: $1,000 per security; issue price: 100%.
- Contingent coupon: $15.9584 per quarter (≈19.15% p.a.) paid on any determination date where MRK closes ≥85% of the initial price ($68.27).
- Memory feature: unpaid coupons accrue and are paid once the downside threshold is again met.
- Auto-call: if MRK closes ≥100% of the initial price ($80.32) on any determination date (except final), the note is redeemed at par plus the current and any unpaid coupons.
- Principal risk: if the note is not called and MRK is <85% of the initial price on the final determination date, repayment equals the cash value, exposing investors to a leveraged downside of ≈1.1765% for every 1% drop below the threshold. Maximum loss is 100% of principal.
- Maturity: one year; determination dates run monthly from July 2025 to June 2026; coupons/payments follow 3-5 days later.
- Credit: unsubordinated, unsecured debt of UBS AG; all payments subject to UBS credit risk.
- Liquidity: the securities will not be listed on any exchange; secondary trading (if any) will be on a dealer basis. Initial settlement T+3 versus market standard T+1.
- Estimated initial value: $994.20 (99.42% of par), reflecting internal funding and dealer margins.
- Distribution: UBS Securities LLC purchases at 99.90% and resells to Morgan Stanley Wealth Management, which earns a combined $1.00 per $1,000 in fixed sales commission and structuring fee.
Investor considerations: the high headline coupon and memory feature may appeal to yield-seeking investors tolerant of equity risk in MRK and UBS credit risk. However, coupon payments are contingent, principal is not protected, downside is leveraged below an 85% barrier, and liquidity is limited. The small deal size ($12 million) suggests minimal balance-sheet impact for UBS and limited secondary market depth for holders.